BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 8142619)

  • 1. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
    Xia Y; Hwang LY; Cobb MH; Baer R
    Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
    Hofmann TJ; Cole MD
    Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia.
    Xia Y; Brown L; Yang CY; Tsan JT; Siciliano MJ; Espinosa R; Le Beau MM; Baer RJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11416-20. PubMed ID: 1763056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIM domain proteins in leukaemia and development.
    Sánchez-García I; Rabbitts TH
    Semin Cancer Biol; 1993 Dec; 4(6):349-58. PubMed ID: 8142620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
    Cheng JT; Hsu HL; Hwang LY; Baer R
    Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
    Hunger SP; Cleary ML
    Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.
    Mahajan MA; Park ST; Sun XH
    Oncogene; 1996 Jun; 12(11):2343-50. PubMed ID: 8649774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
    Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, chromosome mapping, and expression of the mouse Lyl-1 gene.
    Kuo SS; Mellentin JD; Copeland NG; Gilbert DJ; Jenkins NA; Cleary ML
    Oncogene; 1991 Jun; 6(6):961-8. PubMed ID: 2067848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.
    Wadman I; Li J; Bash RO; Forster A; Osada H; Rabbitts TH; Baer R
    EMBO J; 1994 Oct; 13(20):4831-9. PubMed ID: 7957052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
    Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
    Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas-specific basic helix-loop-helix protein.
    Krapp A; Knöfler M; Frutiger S; Hughes GJ; Hagenbüchle O; Wellauer PK
    EMBO J; 1996 Aug; 15(16):4317-29. PubMed ID: 8861960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
    Grutz G; Forster A; Rabbitts TH
    Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL.
    Marculescu R; Vanura K; Le T; Simon P; Jäger U; Nadel B
    Nat Genet; 2003 Mar; 33(3):342-4. PubMed ID: 12567187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain.
    Wadman IA; Hsu HL; Cobb MH; Baer R
    Oncogene; 1994 Dec; 9(12):3713-6. PubMed ID: 7970731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
    Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
    Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.